PTC Therapeutics, Inc. (PTCT)
73.57
+0.56
(+0.77%)
USD |
NASDAQ |
Apr 15, 16:00
73.12
-0.45
(-0.61%)
After-Hours: 04:34
PTC Therapeutics Research and Development Expense (Quarterly) : 133.13M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Insmed, Inc. | 254.91M |
| Sarepta Therapeutics, Inc. | 319.50M |
| Keros Therapeutics, Inc. | 17.83M |
| Madrigal Pharmaceuticals, Inc. | 115.88M |
| Protagonist Therapeutics, Inc. | 46.36M |